Last reviewed · How we verify

Bisacodyl plus PEG-CS

European Institute of Oncology · Phase 3 active Small molecule

Bisacodyl plus PEG-CS is a bowel preparation combining a stimulant laxative with polyethylene glycol and electrolytes to cleanse the colon.

Bisacodyl plus PEG-CS is a bowel preparation combining a stimulant laxative with polyethylene glycol and electrolytes to cleanse the colon. Used for Bowel cleansing prior to colonoscopy or other colorectal procedures.

At a glance

Generic nameBisacodyl plus PEG-CS
Also known asLOVOLdyl plus LOVOLesse
SponsorEuropean Institute of Oncology
Drug classBowel preparation agent / Laxative combination
ModalitySmall molecule
Therapeutic areaGastroenterology
PhasePhase 3

Mechanism of action

Bisacodyl is a diphenylmethane derivative that stimulates colonic peristalsis and increases water secretion in the intestine. PEG-CS (polyethylene glycol with electrolytes) provides osmotic laxation to retain water in the bowel lumen. Together, they produce rapid, thorough bowel evacuation for colonoscopy preparation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results